{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:22:48Z","timestamp":1757780568040},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,25]],"date-time":"2014-10-25T00:00:00Z","timestamp":1414195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s10822-014-9806-3","type":"journal-article","created":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T19:12:41Z","timestamp":1414177961000},"page":"79-87","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors"],"prefix":"10.1007","volume":"29","author":[{"given":"Steffen","family":"Lindert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorillee","family":"Tallorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quynh G.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Burkart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Andrew","family":"McCammon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,25]]},"reference":[{"key":"9806_CR1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/507S4a","volume":"507","author":"K Bourzac","year":"2014","unstructured":"Bourzac K (2014) Infectious disease: beating the big three. Nature 507:S4\u2013S7","journal-title":"Nature"},{"key":"9806_CR2","doi-asserted-by":"crossref","first-page":"14902","DOI":"10.1073\/pnas.0907740106","volume":"106","author":"SM Rich","year":"2009","unstructured":"Rich SM, Leendertz FH, Xu G, LeBreton M, Djoko CF, Aminake MN, Takang EE, Diffo JL, Pike BL, Rosenthal BM, Formenty P, Boesch C, Ayala FJ, Wolfe ND (2009) The origin of malignant malaria. Proc Natl Acad Sci USA 106:14902\u201314907","journal-title":"Proc Natl Acad Sci USA"},{"key":"9806_CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14728214.2012.702754","volume":"17","author":"S Tschan","year":"2012","unstructured":"Tschan S, Kremsner PG, Mordmuller B (2012) Emerging drugs for malaria. Expert Opin Emerg Drugs 17:319\u2013333","journal-title":"Expert Opin Emerg Drugs"},{"key":"9806_CR4","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/QCO.0b013e32834cd3ed","volume":"24","author":"C O\u2019Brien","year":"2011","unstructured":"O\u2019Brien C, Henrich PP, Passi N, Fidock DA (2011) Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. Curr Opin Infect Dis 24:570\u2013577","journal-title":"Curr Opin Infect Dis"},{"key":"9806_CR5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1473-3099(12)70064-6","volume":"12","author":"GM Nayyar","year":"2012","unstructured":"Nayyar GM, Breman JG, Newton PN, Herrington J (2012) Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis 12:488\u2013496","journal-title":"Lancet Infect Dis"},{"key":"9806_CR6","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.1104063108","volume":"108","author":"N Klonis","year":"2011","unstructured":"Klonis N, Crespo-Ortiz MP, Bottova I, Abu-Bakar N, Kenny S, Rosenthal PJ, Tilley L (2011) Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion. Proc Natl Acad Sci USA 108:11405\u201311410","journal-title":"Proc Natl Acad Sci USA"},{"key":"9806_CR7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/cmdc.201200407","volume":"8","author":"FC Schrader","year":"2013","unstructured":"Schrader FC, Glinca S, Sattler JM, Dahse HM, Afanador GA, Prigge ST, Lanzer M, Mueller AK, Klebe G, Schlitzer M (2013) Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents. ChemMedChem 8:442\u2013461","journal-title":"ChemMedChem"},{"key":"9806_CR8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/AAC.36.1.50","volume":"36","author":"N Elabbadi","year":"1992","unstructured":"Elabbadi N, Ancelin ML, Vial HJ (1992) Use of radioactive ethanolamine incorporation into phospholipids to assess invitro antimalarial activity by the semiautomated microdilution technique. Antimicrob Agents Chemother 36:50\u201355","journal-title":"Antimicrob Agents Chemother"},{"key":"9806_CR9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1550-7408.1982.tb04023.x","volume":"29","author":"HJ Vial","year":"1982","unstructured":"Vial HJ, Thuet MJ, Philippot JR (1982) Phospholipid biosynthesis in synchronous Plasmodium falciparum cultures. J Protozool 29:258\u2013263","journal-title":"J Protozool"},{"key":"9806_CR10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrmicro843","volume":"2","author":"SA Ralph","year":"2004","unstructured":"Ralph SA, van Dooren GG, Waller RF, Crawford MJ, Fraunholz MJ, Foth BJ, Tonkin CJ, Roos DS, McFadden GI (2004) Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat Rev Microbiol 2:203\u2013216","journal-title":"Nat Rev Microbiol"},{"key":"9806_CR11","doi-asserted-by":"crossref","first-page":"12352","DOI":"10.1073\/pnas.95.21.12352","volume":"95","author":"RF Waller","year":"1998","unstructured":"Waller RF, Keeling PJ, Donald RG, Striepen B, Handman E, Lang-Unnasch N, Cowman AF, Besra GS, Roos DS, McFadden GI (1998) Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. Proc Natl Acad Sci USA 95:12352\u201312357","journal-title":"Proc Natl Acad Sci USA"},{"key":"9806_CR12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.chom.2008.11.001","volume":"4","author":"M Yu","year":"2008","unstructured":"Yu M, Kumar TR, Nkrumah LJ, Coppi A, Retzlaff S, Li CD et al (2008) The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites. Cell Host Microbe 4:567\u2013578","journal-title":"Cell Host Microbe"},{"key":"9806_CR13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1747-0285.2012.01389.x","volume":"80","author":"T Qidwai","year":"2012","unstructured":"Qidwai T, Khan F (2012) Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum. Chem Biol Drug Des 80:155\u2013172","journal-title":"Chem Biol Drug Des"},{"key":"9806_CR14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1462-5822.2008.01270.x","volume":"11","author":"AM Vaughan","year":"2009","unstructured":"Vaughan AM, O\u2019Neill MT, Tarun AS, Camargo N, Phuong TM, Aly AS, Cowman AF, Kappe SH (2009) Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cell Microbiol 11:506\u2013520","journal-title":"Cell Microbiol"},{"key":"9806_CR15","doi-asserted-by":"crossref","first-page":"e1002178","DOI":"10.1371\/journal.ppat.1002178","volume":"7","author":"ER Derbyshire","year":"2011","unstructured":"Derbyshire ER, Mota MM, Clardy J (2011) The next opportunity in anti-malaria drug discovery: the liver stage. PLoS Pathog 7:e1002178","journal-title":"PLoS Pathog"},{"key":"9806_CR16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2960","volume":"8","author":"D Mazier","year":"2009","unstructured":"Mazier D, Renia L, Snounou G (2009) A pre-emptive strike against malaria\u2019s stealthy hepatic forms. Nat Rev Drug Discov 8:854\u2013864","journal-title":"Nat Rev Drug Discov"},{"key":"9806_CR17","doi-asserted-by":"crossref","first-page":"30811","DOI":"10.1074\/jbc.274.43.30811","volume":"274","author":"A Roujeinikova","year":"1999","unstructured":"Roujeinikova A, Sedelnikova S, de Boer GJ, Stuitje AR, Slabas AR, Rafferty JB, Rice DW (1999) Inhibitor binding studies on enoyl reductase reveal conformational changes related to substrate recognition. J Biol Chem 274:30811\u201330817","journal-title":"J Biol Chem"},{"key":"9806_CR18","doi-asserted-by":"crossref","first-page":"30316","DOI":"10.1074\/jbc.273.46.30316","volume":"273","author":"RJ Heath","year":"1998","unstructured":"Heath RJ, Yu YT, Shapiro MA, Olson E, Rock CO (1998) Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis. J Biol Chem 273:30316\u201330320","journal-title":"J Biol Chem"},{"key":"9806_CR19","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0006-291X(83)80050-3","volume":"115","author":"T Hayashi","year":"1983","unstructured":"Hayashi T, Yamamoto O, Sasaki H, Kawaguchi A, Okazaki H (1983) Mechanism of action of the antibiotic thiolactomycin inhibition of fatty acid synthesis of Escherichia coli. Biochem Biophys Res Commun 115:1108\u20131113","journal-title":"Biochem Biophys Res Commun"},{"key":"9806_CR20","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1016\/S0021-9258(18)83280-X","volume":"264","author":"S Jackowski","year":"1989","unstructured":"Jackowski S, Murphy CM, Cronan JE Jr, Rock CO (1989) Acetoacetyl-acyl carrier protein synthase. A target for the antibiotic thiolactomycin. J Biol Chem 264:7624\u20137629","journal-title":"J Biol Chem"},{"key":"9806_CR21","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/oxfordjournals.jbchem.a135614","volume":"99","author":"I Nishida","year":"1986","unstructured":"Nishida I, Kawaguchi A, Yamada M (1986) Effect of thiolactomycin on the individual enzymes of the fatty acid synthase system in Escherichia coli. J Biochem 99:1447\u20131454","journal-title":"J Biochem"},{"key":"9806_CR22","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1126\/science.274.5295.2107","volume":"274","author":"C Baldock","year":"1996","unstructured":"Baldock C, Rafferty JB, Sedelnikova SE, Baker PJ, Stuitje AR, Slabas AR, Hawkes TR, Rice DW (1996) A mechanism of drug action revealed by structural studies of enoyl reductase. Science 274:2107\u20132110","journal-title":"Science"},{"key":"9806_CR23","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1021\/bi0008940","volume":"39","author":"SL Parikh","year":"2000","unstructured":"Parikh SL, Xiao G, Tonge PJ (2000) Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid. Biochemistry 39:7645\u20137650","journal-title":"Biochemistry"},{"key":"9806_CR24","doi-asserted-by":"crossref","first-page":"25436","DOI":"10.1074\/jbc.M701813200","volume":"282","author":"JS Freundlich","year":"2007","unstructured":"Freundlich JS, Wang F, Tsai HC, Kuo M, Shieh HM, Anderson JW et al (2007) X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy. J Biol Chem 282:25436\u201325444","journal-title":"J Biol Chem"},{"key":"9806_CR25","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1021\/jm061257w","volume":"50","author":"G Kumar","year":"2007","unstructured":"Kumar G, Parasuraman P, Sharma SK, Banerjee T, Karmodiya K, Surolia N, Surolia A (2007) Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase. J Med Chem 50:2665\u20132675","journal-title":"J Med Chem"},{"key":"9806_CR26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0020-7519(01)00111-4","volume":"31","author":"R McLeod","year":"2001","unstructured":"McLeod R, Muench SP, Rafferty JB, Kyle DE, Mui EJ, Kirisits MJ, Mack DG, Roberts CW, Samuel BU, Lyons RE, Dorris M, Milhous WK, Rice DW (2001) Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. Int J Parasitol 31:109\u2013113","journal-title":"Int J Parasitol"},{"key":"9806_CR27","doi-asserted-by":"crossref","unstructured":"Tallorin L, Durrant JD, Nguyen QG, McCammon JA, Burkart MD (2014) Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase. Biorgan Med Chem. doi: 10.1016\/j.bmc.2014.09.002","DOI":"10.1016\/j.bmc.2014.09.002"},{"key":"9806_CR28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jmb.2004.08.033","volume":"343","author":"LS Pidugu","year":"2004","unstructured":"Pidugu LS, Kapoor M, Surolia N, Surolia A, Suguna K (2004) Structural basis for the variation in triclosan affinity to enoyl reductases. J Mol Biol 343:147\u2013155","journal-title":"J Mol Biol"},{"key":"9806_CR29","doi-asserted-by":"crossref","first-page":"12514","DOI":"10.1021\/bi9907779","volume":"38","author":"WH Ward","year":"1999","unstructured":"Ward WH, Holdgate GA, Rowsell S, McLean EG, Pauptit RA, Clayton E et al (1999) Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan. Biochemistry 38:12514\u201312525","journal-title":"Biochemistry"},{"key":"9806_CR30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2174\/138945007780058942","volume":"8","author":"JS Oliveira","year":"2007","unstructured":"Oliveira JS, Vasconcelos IB, Moreira IS, Santos DS, Basso LA (2007) Enoyl reductases as targets for the development of anti-tubercular and anti-malarial agents. Curr Drug Targets 8:399\u2013411","journal-title":"Curr Drug Targets"},{"key":"9806_CR31","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1021\/jm400637m","volume":"56","author":"F Belluti","year":"2013","unstructured":"Belluti F, Perozzo R, Lauciello L, Colizzi F, Kostrewa D, Bisi A, Gobbi S, Rampa A, Bolognesi ML, Recanatini M, Brun R, Scapozza L, Cavalli A (2013) Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI). J Med Chem 56:7516\u20137526","journal-title":"J Med Chem"},{"key":"9806_CR32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1517\/13543776.2011.581227","volume":"21","author":"X Lu","year":"2011","unstructured":"Lu X, Huang K, You Q (2011) Enoyl acyl carrier protein reductase inhibitors: a patent review (2006\u20132010). Expert Opin Ther Pat 21:1007\u20131022","journal-title":"Expert Opin Ther Pat"},{"key":"9806_CR33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/iub.327","volume":"62","author":"K Maity","year":"2010","unstructured":"Maity K, Bhargav SP, Sankaran B, Surolia N, Surolia A, Suguna K (2010) X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition. IUBMB Life 62:467\u2013476","journal-title":"IUBMB Life"},{"key":"9806_CR34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/156802609789207127","volume":"9","author":"AD Andricopulo","year":"2009","unstructured":"Andricopulo AD, Salum LB, Abraham DJ (2009) Structure-based drug design strategies in medicinal chemistry. Curr Top Med Chem 9:771\u2013790","journal-title":"Curr Top Med Chem"},{"key":"9806_CR35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.5012\/bkcs.2011.32.1.162","volume":"32","author":"HM Lee","year":"2011","unstructured":"Lee HM, Singh NJ (2011) Understanding drug\u2013protein interactions in Escherichia coli FabI and various fabi inhibitor complexes. B Korean Chem Soc 32:162\u2013168","journal-title":"B Korean Chem Soc"},{"key":"9806_CR36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/qsar.200530182","volume":"25","author":"KFM Pasqualoto","year":"2006","unstructured":"Pasqualoto KFM, Ferreira MMC (2006) Application of a receptor pruning methodology to the enoyl-ACP reductase from Escherichia coli (Fabl). QSAR Comb Sci 25:629\u2013636","journal-title":"QSAR Comb Sci"},{"key":"9806_CR37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jsb.2010.11.008","volume":"174","author":"NJ Singh","year":"2011","unstructured":"Singh NJ, Shin D, Lee HM, Kim HT, Chang HJ, Cho JM, Kim KS, Ro S (2011) Structural basis of triclosan resistance. J Struct Biol 174:173\u2013179","journal-title":"J Struct Biol"},{"key":"9806_CR38","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3390\/molecules15020780","volume":"15","author":"L Yang","year":"2010","unstructured":"Yang L, Liu Y, Sternberg C, Molin S (2010) Evaluation of enoyl-acyl carrier protein reductase inhibitors as Pseudomonas aeruginosa quorum-quenching reagents. Molecules 15:780\u2013792","journal-title":"Molecules"},{"key":"9806_CR39","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/pro.2155","volume":"21","author":"S Lindert","year":"2012","unstructured":"Lindert S, McCammon JA (2012) Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery. Protein Sci 21:1734\u20131745","journal-title":"Protein Sci"},{"key":"9806_CR40","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbrc.2007.04.113","volume":"358","author":"G Nicola","year":"2007","unstructured":"Nicola G, Smith CA, Lucumi E, Kuo MR, Karagyozov L, Fidock DA, Sacchettini JC, Abagyan R (2007) Discovery of novel inhibitors targeting enoyl-acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening. Biochem Biophys Res Commun 358:686\u2013691","journal-title":"Biochem Biophys Res Commun"},{"key":"9806_CR41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11030-009-9141-0","volume":"13","author":"VA Morde","year":"2009","unstructured":"Morde VA, Shaikh MS, Pissurlenkar RR, Coutinho EC (2009) Molecular modeling studies, synthesis, and biological evaluation of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR) inhibitors. Mol Divers 13:501\u2013517","journal-title":"Mol Divers"},{"key":"9806_CR42","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1016\/j.ejmech.2008.12.028","volume":"44","author":"V Frecer","year":"2009","unstructured":"Frecer V, Megnassan E, Miertus S (2009) Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase. Eur J Med Chem 44:3009\u20133019","journal-title":"Eur J Med Chem"},{"key":"9806_CR43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/1062936X.2010.502297","volume":"21","author":"P Shah","year":"2010","unstructured":"Shah P, Siddiqi MI (2010) 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors. SAR QSAR Environ Res 21:527\u2013545","journal-title":"SAR QSAR Environ Res"},{"key":"9806_CR44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","volume":"22","author":"K Arnold","year":"2006","unstructured":"Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195\u2013201","journal-title":"Bioinformatics"},{"key":"9806_CR45","doi-asserted-by":"crossref","first-page":"W522","DOI":"10.1093\/nar\/gkm276","volume":"35","author":"TJ Dolinsky","year":"2007","unstructured":"Dolinsky TJ, Czodrowski P, Li H, Nielsen JE, Jensen JH, Klebe G, Baker NA (2007) PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res 35:W522\u2013W525","journal-title":"Nucleic Acids Res"},{"key":"9806_CR46","doi-asserted-by":"crossref","first-page":"W665","DOI":"10.1093\/nar\/gkh381","volume":"32","author":"TJ Dolinsky","year":"2004","unstructured":"Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA (2004) PDB2PQR: an automated pipeline for the setup of Poisson\u2013Boltzmann electrostatics calculations. Nucleic Acids Res 32:W665\u2013W667","journal-title":"Nucleic Acids Res"},{"key":"9806_CR47","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791","journal-title":"J Comput Chem"},{"key":"9806_CR48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234","journal-title":"J Comput Aided Mol Des"},{"key":"9806_CR49","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749","journal-title":"J Med Chem"},{"key":"9806_CR50","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750\u20131759","journal-title":"J Med Chem"},{"key":"9806_CR51","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1021\/ci700376c","volume":"48","author":"HS Lee","year":"2008","unstructured":"Lee HS, Choi J, Kufareva I, Abagyan R, Filikov A, Yang Y, Yoon S (2008) Optimization of high throughput virtual screening by combining shape-matching and docking methods. J Chem Inf Model 48:489\u2013497","journal-title":"J Chem Inf Model"},{"key":"9806_CR52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326","journal-title":"Adv Drug Deliv Rev"},{"key":"9806_CR53","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2009","unstructured":"Trott O, Olson AJ (2009) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461","journal-title":"J Comput Chem"},{"key":"9806_CR54","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49:6177\u20136196","journal-title":"J Med Chem"},{"key":"9806_CR55","doi-asserted-by":"crossref","unstructured":"Lindert S, Zhu W, Liu YL, Pang R, Oldfield E, McCammon JA (2013) Farnesyl diphosphate synthase inhibitors from in silico screening. Chem Biol Drug Des 81(6):742\u2013748","DOI":"10.1111\/cbdd.12121"},{"key":"9806_CR56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jmgm.2010.05.008","volume":"29","author":"J Duan","year":"2010","unstructured":"Duan J, Dixon SL, Lowrie JF, Sherman W (2010) Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods. J Mol Graph Model 29:157\u2013170","journal-title":"J Mol Graph Model"},{"key":"9806_CR57","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1021\/ci100062n","volume":"50","author":"M Sastry","year":"2010","unstructured":"Sastry M, Lowrie JF, Dixon SL, Sherman W (2010) Large-scale systematic analysis of 2D fingerprint methods and parameters to improve virtual screening enrichments. J Chem Inf Model 50:771\u2013784","journal-title":"J Chem Inf Model"},{"key":"9806_CR58","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1074\/jbc.M112000200","volume":"277","author":"R Perozzo","year":"2002","unstructured":"Perozzo R, Kuo M, Sidhu AS, Valiyaveettil JT, Bittman R, Jacobs WR Jr, Fidock DA, Sacchettini JC (2002) Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase. J Biol Chem 277:13106\u201313114","journal-title":"J Biol Chem"},{"key":"9806_CR59","doi-asserted-by":"crossref","first-page":"28201","DOI":"10.1074\/jbc.M003241200","volume":"275","author":"KH Choi","year":"2000","unstructured":"Choi KH, Kremer L, Besra GS, Rock CO (2000) Identification and substrate specificity of beta-ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis. J Biol Chem 275:28201\u201328207","journal-title":"J Biol Chem"},{"key":"9806_CR60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/84612","volume":"7","author":"N Surolia","year":"2001","unstructured":"Surolia N, Surolia A (2001) Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat Med 7:167\u2013173","journal-title":"Nat Med"},{"key":"9806_CR61","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1042\/BJ20040302","volume":"381","author":"M Kapoor","year":"2004","unstructured":"Kapoor M, Gopalakrishnapai J, Surolia N, Surolia A (2004) Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum. Biochem J 381:735\u2013741","journal-title":"Biochem J"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-014-9806-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-014-9806-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-014-9806-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T10:05:46Z","timestamp":1717495546000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-014-9806-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,25]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["9806"],"URL":"https:\/\/doi.org\/10.1007\/s10822-014-9806-3","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,25]]}}}